Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Bridge to New Markets.

Viennese start-up carries out research on drug to fight tuberculosis

"We are beginning with tuberculosis", the CEO added. The California-based biotech company Trianni Inc. which Wabl established a few years ago has ensured the necessary pre-requisites for this. “The main problem is the resistance against antibiotics, but there is an alternative, namely antibodies”, said the trained chemist and biologist, who teaches microbiology and immunology at the American university. Trianni created the platform enabling the antibodies to be identified. This means genetic mice developed for this purpose. In addition to various pharmaceutical companies, Austrianni is one of the licensees of the patented antibody platform and can continue researching on this basis. The mice mentioned above produce the humanized antibodies needed to fight tuberculosis and other diseases.

The business location decision of Austrianni was not only based on the roots of the company’s founder in Austria. „There are very generous funding possibilities here. This is one of the main reasons“, Wabl added. Up to 70 percent of the project costs can be contributed by the Austrian Research Promotion Agency FFG. Moreover, Austria “is making great efforts to expand its biotech sector”, Wabl concluded.

 

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Business Location Austria

    24.09.2019, Bucharest, Romania

  • Business Location Austria

    25.09.2019, Cluj-Napoca, Romania

Austria Map

Find the perfect location for your company

One of Austria's key strengths as a business destination is its highly qualified and motivated skilled workforce for research and development, especially in the scientific sector.

Nestlé Austria

Logo
More testimonials

news from the business location Austria

ERC Starting Grant for molecular biologist in Innsbruck

The molecular biologist Jerome Mertens received a Starting Grant of the European Research Council (ERC) for his research into understanding the molecular and cellular causes of aging, especially brain aging and molecular cell biology of Alzheimer's disease in nerve cells.

Not Only for Startups: The Business Plan as the Road Map to Success

A great idea has been born. The product the world is waiting for has been invented. Actually, nothing can seemingly go wrong. At least one would be inclined to think so. However, the best idea or invention is worthless without a business plan to successfully bring the idea down to earth. Here you will find out what you should take into consideration when drawing up a business plan.

More news All blog posts